Skip to main content
. 2004 Jul;6(3):236–246. doi: 10.1215/S1152851703000668

Fig. 2.

Fig. 2

Antitumor ELISA. Patient serum was diluted in blocking buffer and added to tumor lysate–coated wells and PBMC lysate–coated wells (control for nonspecific binding; data not shown). Panel A shows the results for patient 4, and Panel B shows the results for patient 7. Error bars represent standard deviations of the mean from triplicate samples.